International comparisons of the management of patients with non-ST segment elevation acute myocardial infarction in the United Kingdom, Sweden, and the United States: The MINAP/NI... von McNamara, R.L, Chung, S.C, Jernberg, T, Holmes, D, Roe, M, Timmis, A, James, S, Deanfield, J, Fonarow, G.C, Peterson, E.D, Jeppsson, A, Hemingway, H

Volltext

Secondary preventive medication persistence and adherence 1 year after stroke von BUSHNELL, C. D, OLSON, D. M, KIDWELL, C, LABRESH, K. A, OVBIAGELE, B, SCHWAMM, L, PETERSON, E. D, ZHAO, X, PAN, W, ZIMMER, L. O, GOLDSTEIN, L. B, ALBERTS, M. J, FAGAN, S. C, FONAROW, G. C, JOHNSTON, S. C

Volltext

Regional Differences in Utilization and Outcomes of Left Ventricular Assist Devices: Insights from the INTERMACS Registry von Krim, S.R, Vivo, R.P, Campbell, P.T, Naftel, D.C, Estep, J.D, Fonarow, G.C, Ventura, H.O

Volltext

Body Mass Index Adversely Affects Survival in Left Ventricular Assist Device Bridged Patients Undergoing Heart Transplantation von Deo, S, Kumar, S, Altarabsheh, S, Kerner, J, Benavides, J, Sareyyupoglu, B, Medalion, B, Elgudin, Y, Elamm, C, Ginwalla, M, Benatti, R, Zacharias, M, Oliveira, G.H, Fonarow, G.C, Park, S.J

Volltext

285 Contemporary Use of Renin-Angiotensin System Blockers in Acute Coronary Syndromes: Findings From Get With The Guidelines-Coronary Artery Disease Program von Bainey, K.R, Fonarow, G.C, Bhatt, D.L

Volltext

How Do Readmissions Impact Survival Among Patients with Continuous-Flow Left Ventricular Assist Devices? Findings from INTERMACS von Vivo, R.P, Krim, S.R, Estep, J.D, Khalife, W.I, Fonarow, G.C, Kormos, R.L, Myers, S.L, Deng, M.C

Volltext

Comparison of Survival between Pediatric and Adult Patients after Biventricular Assist Device Implantation: Analysis of the UNOS Database von DePasquale, E.C, Vivo, R.P, Nsair, A, Cadeiras, M, Cruz, D, Ardehali, R, Baas, A.S, Deng, M.C, Fonarow, G.C, Reardon, L.C, Ardehali, A

Volltext

Aquapheresis Versus Intravenous Diuretics and Hospitalizations for Heart Failure (AVOID-HF) Trial von Costanzo, M.R., MD, Negoianu, D., MD, Jaski, B.E., MD, Bart, B.A., MD, Heywood, J.T., MD, Anand, I.S., MD, DPhil (Oxon), Smelser, J., MD, Kaneshige, A.M., MD, Chomsky, D.B., MD, Adler, E.D., MD, Haas, G.J., MD, Watts, J.A., MD, Nabut, J.L., MS, Schollmeyer, M.P., DVM, Fonarow, G.C

Volltext

Clinical Effectiveness of CRT and ICD Therapy in Men and Women with Heart Failure: Findings from IMPROVE HF von Wilcox, J.E, Fonarow, G.C, Zhang, Yan, Albert, N.M, Curtis, A.B, Gheorghiade, M, Heywood, J.T, Mehra, M.R, O'Connor, C.M, Walsh, M.N, Reynolds, D, Yancy, C.W

Volltext

Patients With Biventricular Mechanical Support Can Be Safely Discharged to Home To Await Heart Transplant von Creaser, J.W, Rourke, D, Harrison, T, Vandenbogaart, E, Livingston, N, Howell, E, Huie, N, Baas, A, Hickey, A, Nsair, A, Deng, M, Fonarow, G.C, Cheng, R, Shemin, R, MacLellan, W.R

Volltext

Clinical Characteristics and Outcomes for Hospitalized Heart Failure (HF) Patients with Chronic Obstructive Pulmonary Disease (COPD): Findings from OPTIMIZE-HF von Mentz, R.J, Fiuzat, M, Wojdyla, D, Chiswell, K, Pieper, K, Gheorghiade, M, Fonarow, G.C, O'Connor, C.M

Volltext

223: Brain Gray Matter Loss in Heart Failure Is Gender-Dependent von Woo, M.A, Kumar, R, Macey, P.M, Fonarow, G.C, Hamilton, M.A, Harper, R.M

Volltext

PCV38 The IMPACT on Clinical an Economic VALUE of Patient Prioritization According to Risk: Evolocumab in Patients with Myocardial Infarction in Sweden von Hagström, E., Lindgren, P., Villa, G., Martinez, L., Arellano, J., Eriksson Svensson, M., Fonarow, G.C.

Volltext

Cost-effectiveness of evolocumab in patients with familial hypercholesterolemia in Belgium von Descamps, O.S., Van Hout, B., Lindgren, P., Villa, G., Urbich, M., Fonarow, G.C.

Volltext

Influence of Race on Improvements in Use of Guideline Recommended Heart Failure Therapies: Findings from IMPROVE HF von Reynolds, D.W, Albert, N.M, Curtis, A.B, Gheorghiade, M, Heywood, J.T, Inge, P. Johnson, McBride, M.L, Mehra, M.R, O'Connor, C.M, Walsh, M.N, Yancy, C.W, Fonarow, G.C

Volltext

PCV40 COST-EFFECTIVENESS OF EVOLOCUMAB IN ATHEROSCLEROTIC CARDIOVASCULAR DISEASE PATIENTS WITH VARYING RISK PROFILES IN SWEDEN von Lindgren, P., Hagström, E., van Hout, B., Villa, G., Pemberton-Ross, P., Arellano, J., Sibartie, M., Fonarow, G.C.

Volltext

PCV57 A Systematic Literature Review of Cost-Utility Analyses of PCSK9 Inhibitors von Villa, G., Postma, M., Heeg, B., Kroi, F., Sidelnikov, E., Gomez Montero, M., Abbas, Z., Hashim, M., Stollenwerk, B., Fonarow, G.C.

Volltext

Prevalence and Characteristics of Prolonged QRS Duration in Outpatients with Left Ventricular Systolic Dysfunction: An IMPROVE HF Analysis von Heywood, J.T, Fonarow, G.C, Yancy, C.W, Albert, N.M, Curtis, A.B, Stough, W. Gattis, Gheorghiade, M, McBride, M.L, Mehra, M, O'Connor, C, Reynolds, D, Walsh, M.N

Volltext

BNP Levels in Outpatients with Heart Failure: Frequency of Assessment, Relationship to Symptoms, Disease Severity, and HF Quality of Care Measures von Gheorghiade, M, Fonarow, G.C, Yancy, C.W, Albert, N.M, Curtis, A.B, Stough, W. Gattis, Heywood, J.T, McBride, M.L, Mehra, M, O'Connor, C, Reynolds, D, Walsh, M.N

Volltext

Influence of Atrial Fibrillation on the Use of CRT and ICD Therapy in Heart Failure: Findings from IMPROVE HF von Curtis, A.B, Fonarow, G.C, Yancy, C.W, Albert, N.M, Stough, W. Gattis, Gheorghiade, M, Heywood, J.T, McBride, M.L, Mehra, M, O'Connor, C, Reynolds, D, Walsh, M.N

Volltext